Our Pricing

Wegovy Private Prescription UK - All Doses In Stock

Published on: June 03, 2026

Securing a wegovy private prescription uk service with guaranteed stock availability has become essential as demand continues to outpace supply across the country. At Cured Pharmacy, we maintain all Wegovy doses in stock with transparent upfront pricing from £79.00, UK-registered prescribers offering free consultations under 3 minutes, and 100% discreet nationwide delivery.

How Wegovy Works for Weight Loss

Wegovy contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist licensed by the MHRA for chronic weight management in adults with a BMI of 30 kg/m² or greater, or 27 kg/m² with at least one weight-related comorbidity [1]. The medication mimics a natural hormone that regulates appetite and food intake by acting on areas of the brain responsible for hunger signals.

In the landmark STEP 1 clinical trial, participants using Wegovy alongside lifestyle interventions achieved an average weight reduction of 14.9% over 68 weeks, compared to 2.4% with placebo [1]. The once-weekly subcutaneous injection provides sustained therapeutic levels throughout the week, eliminating the need for daily dosing and improving treatment adherence in real-world settings.

Semaglutide works through multiple mechanisms: it slows gastric emptying to prolong satiety after meals, reduces appetite by acting on hypothalamic centres, and may influence reward pathways associated with food preferences [2]. These combined effects create a physiological environment conducive to sustained caloric reduction without the extreme hunger often experienced with traditional dietary restriction alone.

Wegovy Dosing Schedule and Titration

Wegovy follows a structured dose escalation protocol designed to minimise gastrointestinal side effects whilst optimising therapeutic response. The standard titration begins at 0.25 mg weekly for four weeks, increasing monthly through 0.5 mg, 1 mg, and 1.7 mg, before reaching the maintenance dose of 2.4 mg weekly [3].

This gradual escalation allows your digestive system to adapt to the medication's effects on gastric motility. Clinical experience from our superintendent pharmacist Tarun Kumar and our UK prescribing team shows that patients who follow the recommended titration schedule experience significantly fewer treatment discontinuations due to nausea or vomiting compared to those who escalate too rapidly.

At Cured Pharmacy, we stock all five Wegovy pen strengths continuously, ensuring uninterrupted treatment progression. Supply interruptions at critical titration points can compromise treatment outcomes, as returning to lower doses after a gap may require restarting the escalation protocol from the beginning, subject to prescriber assessment.

What Happens If You Miss a Dose

If you miss a Wegovy injection and fewer than five days have passed since your scheduled dose, administer it as soon as you remember, then resume your regular weekly schedule [3]. If more than five days have elapsed, skip the missed dose entirely and take your next injection on the regularly scheduled day to avoid overlapping therapeutic peaks.

Extended gaps beyond two weeks may require dose adjustment or retitration, depending on your prescriber's clinical judgement. Our clinical team at Cured Pharmacy provides guidance on managing missed doses during your treatment journey, ensuring safe continuation without unnecessary setbacks.

Wegovy Private Prescription UK: Clinical Assessment Process

All Wegovy prescriptions at Cured Pharmacy require completion of a clinical assessment by a UK-registered prescriber, in full compliance with General Pharmaceutical Council (GPhC) and MHRA regulations. Our online consultation takes under three minutes and covers your medical history, current medications, weight management goals, and any contraindications to GLP-1 therapy.

Your assessment is reviewed by a qualified UK prescriber who determines medical suitability based on NICE guidance for obesity management. Wegovy is not appropriate for everyone: absolute contraindications include personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, pregnancy, breastfeeding, and severe gastrointestinal disease [3].

Once approved, your prescription is dispensed by our GPhC-registered pharmacy (registration number 9012511) and dispatched in discreet packaging with no external pharmacy branding. We provide clear injection instructions, storage guidance (refrigerate between 2°C and 8°C before first use), and ongoing clinical support throughout your treatment course.

Who Can Prescribe Wegovy Privately in the UK

Private Wegovy prescriptions must be issued by UK-registered prescribers operating within their scope of practice—typically GPs, nurse prescribers, or pharmacist prescribers with appropriate training in obesity management. At Cured Pharmacy, our clinical team includes prescribers registered with the General Medical Council (GMC) and Nursing and Midwifery Council (NMC), all operating under the clinical governance framework overseen by our superintendent pharmacist Tarun Kumar (GPhC 2233073).

Every prescription is individualised based on your clinical assessment. We never issue repeat prescriptions automatically; each supply requires confirmation that treatment remains appropriate, side effects are manageable, and weight loss progress justifies continuation, in line with NICE recommendations for ongoing obesity pharmacotherapy.

Wegovy Side Effects and Management Strategies

The most commonly reported side effects with Wegovy are gastrointestinal: nausea affects approximately 44% of patients, diarrhoea 30%, vomiting 24%, and constipation 24%, predominantly during the dose escalation phase [1]. These effects typically diminish as your body adapts to each new dose level, with most patients reporting substantial improvement after four to eight weeks on the maintenance dose.

Practical management strategies include eating smaller, more frequent meals rather than large portions, avoiding high-fat foods that delay gastric emptying further, staying well-hydrated, and timing your injection consistently each week to establish predictable symptom patterns. Ginger supplements and prescribed antiemetics may provide additional relief for persistent nausea, subject to prescriber approval.

Rare but serious adverse effects include pancreatitis (symptoms: severe persistent abdominal pain radiating to the back), gallbladder disease, acute kidney injury secondary to dehydration from vomiting, and hypoglycaemia in patients taking concomitant diabetes medications [3]. Any severe or persistent symptoms warrant immediate medical review, and our clinical team at Cured Pharmacy remains available to advise on symptom management or treatment modifications throughout your course.

Wegovy vs Saxenda: Comparing GLP-1 Weight Loss Treatments

Both Wegovy and Saxenda are MHRA-licensed GLP-1 receptor agonists for weight management, but they differ significantly in dosing frequency, efficacy profile, and patient convenience. Saxenda contains liraglutide and requires daily subcutaneous injection, whilst Wegovy's semaglutide formulation provides once-weekly dosing due to its extended half-life of approximately one week [2][4].

Head-to-head clinical data demonstrates superior weight loss outcomes with semaglutide: the STEP 8 trial showed participants on Wegovy achieved 15.8% average weight reduction compared to 6.4% with Saxenda over 68 weeks [5]. The once-weekly injection schedule also improves long-term adherence, particularly for patients who find daily injections burdensome or who travel frequently for work.

Treatment selection depends on individual clinical factors, previous medication responses, and personal preferences regarding injection frequency. Some patients prefer the flexibility of daily dosing to manage side effects more granularly, whilst others prioritise the convenience and superior efficacy data associated with weekly semaglutide. Your UK prescriber will discuss these considerations during your clinical assessment to determine the most appropriate option for your circumstances.

Can You Switch Between Wegovy and Saxenda

Switching between GLP-1 therapies is possible under prescriber supervision, though it requires careful consideration of cross-titration protocols to minimise side effects. If transitioning from daily Saxenda to weekly Wegovy, most prescribers recommend starting Wegovy at the initial 0.25 mg dose despite prior GLP-1 exposure, as the pharmacokinetic profiles differ substantially [3][4].

Conversely, switching from Wegovy to Saxenda may allow for a slightly accelerated Saxenda titration, though individual tolerance varies. Our prescribing team at Cured Pharmacy assesses each switch request individually, considering your treatment history, reasons for switching, and current metabolic control before recommending a safe transition protocol.

Wegovy Pricing and Stock Availability at Cured Pharmacy

Wegovy is available at Cured Pharmacy from £79.00, with transparent upfront pricing displayed before you begin your clinical consultation. Unlike some providers who reveal costs only after assessment, we believe in complete price transparency so you can make informed decisions about your weight management investment without unexpected charges.

We maintain continuous stock of all five Wegovy pen strengths (0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg), addressing the widespread supply challenges that have affected UK pharmacies throughout 2023 and 2024. Our procurement relationships with licensed UK wholesalers and commitment to inventory management ensure that your treatment progression is never delayed by stock unavailability.

Your Wegovy prescription includes the medication supply, clinical assessment by a UK-registered prescriber, dispensing by our GPhC-registered pharmacy, and discreet next-day delivery across the UK. We provide injection supplies (needles are integrated into the pre-filled pens), comprehensive usage instructions, and ongoing clinical support throughout your treatment course. Patients continuing beyond the initial prescription period receive £79.00 off subsequent orders, reinforcing our commitment to accessible long-term weight management support.

Scientific References

1. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wadden, T. A., Wharton, S., Yokote, K., Zeuthen, N., Kushner, R. F., & STEP 1 Study Group. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
2. Müller, T. D., Finan, B., Bloom, S. R., D'Alessio, D., Drucker, D. J., Flatt, P. R., Fritsche, A., Gribble, F., Grill, H. J., Habener, J. F., Holst, J. J., Langhans, W., Meier, J. J., Nauck, M. A., Perez-Tilve, D., Pocai, A., Reimann, F., Sandoval, D. A., Schwartz, T. W., ... Tschöp, M. H. (2019). Glucagon-like peptide 1 (GLP-1). Molecular Metabolism, 30, 72–130. https://doi.org/10.1016/j.molmet.2019.09.010 [accessed 13 August 2026]
3. Electronic Medicines Compendium. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen - Summary of Product Characteristics (SmPC). Retrieved from https://www.medicines.org.uk/emc/product/13799/smpc [accessed 13 August 2026]
4. Electronic Medicines Compendium. (2023). Saxenda 6 mg/ml solution for injection in pre-filled pen - Summary of Product Characteristics (SmPC). Retrieved from https://www.medicines.org.uk/emc/product/2313/smpc [accessed 13 August 2026]
5. Rubino, D. M., Greenway, F. L., Khalid, U., O'Neil, P. M., Rosenstock, J., Sørrig, R., Wadden, T. A., Wizert, A., Garvey, W. T., & STEP 8 Investigators. (2022). Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial. JAMA, 327(2), 138–150. https://doi.org/10.1001/jama.2021.23619 [accessed 13 August 2026]
6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Wegovy is a prescription-only medicine and individual results may vary based on adherence to treatment and lifestyle modifications.